Intrinsic Value of S&P & Nasdaq Contact Us

Angion Biomedica Corp. ANGN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
+50%

Stock Statistics — ANGN

Angion Biomedica Corp. (ANGN) has a market capitalization of $30.11M and trades at $1.00. The 52-week range is 1.0-20.4.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-2.58.

The stock has a beta of 0.60, operates in the Healthcare sector.

Trading Data
Current Price$1.00
52-Week Range1.0-20.4
Volume224.8K
Avg Volume (30D)9.77K
Market Cap$30.11M
Beta (1Y)0.60
Company
IPO Date2021-02-05
Employees3
CEOJay R. Venkatesan
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS03476J1079
CUSIP03476J107
Income (Latest Year)
EBITDA$-37.71M
Operating Income$-37.71M
Net Income$-39.57M
EPS$-2.58
EPS Diluted$-2.58
Shares Outstanding$15.31M
Balance Sheet (Latest Year)
Total Assets$25.86M
Current Assets$19.31M
Cash & ST Investments$18.56M
Total Liabilities$24.23M
Total Debt$5.11M
Net Debt$-13.46M
Total Equity$1.64M
Debt / Equity3.12
Valuation Ratios
P/E Ratio-0.4
P/B Ratio18.41
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message